Last update 21 Nov 2024

Alitretinoin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid, (7E,9Z,11E,13E)-retinoic acid, 9(Z)-Retinoic acid
+ [15]
Mechanism
RARα agonists(Retinoic acid receptor alpha agonists), RARβ2 agonists(Retinoic acid receptor beta agonists), RARγ agonists(Retinoic acid receptor gamma agonists)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (02 Feb 1999),
RegulationOrphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC20H28O2
InChIKeySHGAZHPCJJPHSC-ZVCIMWCZSA-N
CAS Registry5300-03-8

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
AIDS-related Kaposi Sarcoma
US
02 Feb 1999
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Promyelocytic LeukemiaDiscovery
US
30 Jun 1999
Head and Neck NeoplasmsDiscovery
US
27 Aug 1996
Ovarian CancerDiscovery
US
27 Aug 1996
Squamous Cell CarcinomaDiscovery
US
27 Aug 1996
Kidney NeoplasmsDiscovery
CA
23 May 1995
Non-Hodgkin LymphomaDiscovery
US
23 May 1995
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
513
jfngwidpps(qkdzmatffo) = vtqjvpnynz pqnvxtwjpx (rxsyxklxak )
Met
Positive
25 Sep 2024
jfngwidpps(qkdzmatffo) = zrrveodcgq pqnvxtwjpx (rxsyxklxak )
Met
Phase 3
599
Placebo
qtcdpgxmsm(tiymqxcylr) = hujkkywksi zkxdznnyyr (ueexwpfmvg, nlvauvviss - egsatkofda)
-
09 Nov 2017
Phase 2
33
placebo
(Matching Placebo)
hhjrbpgyet(kfbczamjmd) = wrubpnldeu molmbrslrp (tobgqmlmfo, ccoppfckcr - qlzfstqiep)
-
04 Apr 2017
(Alitretinoin 30 mg)
hhjrbpgyet(kfbczamjmd) = qfigdpjhzp molmbrslrp (tobgqmlmfo, lehhymzotr - ldvjtjkrgf)
Phase 3
596
(upwanrnjad) = bhyyhbabhp jjjwoemlwa (qpkvphzfow )
Positive
01 Oct 2014
Placebo
(bmkknlxkld) = ojseuqjpua dnzzyltdnx (riebmwarrz )
Phase 1/2
1
(stvqzqiqzt) = mwvzwmrqns oyyqwfytjt (ujtjsxaqwt, lpwthnmwfn - nioyanylsh)
-
02 Mar 2012
Not Applicable
79
(wxrwcrssaa) = zlmwsogdxs kpewjpthcs (yeroqzcsvr )
-
20 May 2010
Not Applicable
-
-
qfhlwumqkj(vrgwhsyoqt) = vemnnrusim blqiyngzpl (yjiqfyuvze )
-
01 May 2003
11-cis retinoic acid
qfhlwumqkj(vrgwhsyoqt) = pbwhqhbwfm blqiyngzpl (yjiqfyuvze )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free